Addiction Counselor

Psychoactive substance use disorder represents a clinical condition characterized by a problematic pattern of substance use leading to clinically significant impairment or distress. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5, now in its text revision, DSM-5-TR) consolidated the previous categories of substance abuse and substance dependence into a single diagnosis called substance use disorder, which exists on a continuum from mild to severe.

The DSM-5 criteria for substance use disorder include eleven symptoms grouped into four categories: impaired control, social impairment, risky use, and pharmacological indicators. Impaired control encompasses taking the substance in larger amounts or over longer periods than intended, persistent desire or unsuccessful efforts to cut down, spending considerable time obtaining, using, or recovering from the substance, and experiencing cravings. Social impairment includes failure to fulfill major role obligations, continued use despite persistent social or interpersonal problems, and giving up important activities. Risky use involves recurrent use in physically hazardous situations and continued use despite knowledge of physical or psychological problems. Pharmacological indicators include tolerance and withdrawal.

The severity of substance use disorder is determined by the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). This dimensional approach replaced the categorical distinction between abuse and dependence, providing a more accurate representation of the clinical reality that substance use problems exist on a spectrum.

Neurobiological research has established that psychoactive substances affect the brain's reward circuitry, particularly the mesolimbic dopamine system. The ventral tegmental area projects dopaminergic neurons to the nucleus accumbens, prefrontal cortex, and amygdala. Repeated substance exposure leads to neuroadaptations in these circuits, contributing to the development of tolerance, withdrawal, and compulsive drug-seeking behavior.

The concept of allostasis explains how chronic substance use shifts the brain's reward set point. Initially, substances produce euphoria by flooding reward circuits with dopamine. Over time, the brain adapts by reducing dopamine receptor sensitivity and production, leading to tolerance. When the substance is absent, the individual experiences a deficit state characterized by dysphoria, anxiety, and craving, which drives continued use to achieve homeostasis.

Genetic factors contribute significantly to substance use disorder vulnerability. Twin studies estimate heritability at 40-60% for most substance use disorders. Specific genetic variants affecting neurotransmitter systems, drug metabolism, and stress response have been identified. However, genetic predisposition interacts with environmental factors including early life stress, trauma, peer influences, and substance availability.

Co-occurring mental health disorders are highly prevalent among individuals with substance use disorders. Approximately 50% of those with severe mental illness also have a substance use disorder, and vice versa. Common comorbidities include depression, anxiety disorders, post-traumatic stress disorder, bipolar disorder, and personality disorders. The relationship between mental health and substance use is bidirectional: substances may be used to self-medicate psychiatric symptoms, while chronic substance use can induce or exacerbate mental health conditions.